Cover Image
市場調查報告書

血液析離設備的全球市場

Apheresis Equipment

出版商 Global Industry Analysts, Inc. 商品編碼 222478
出版日期 內容資訊 英文 214 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
血液析離設備的全球市場 Apheresis Equipment
出版日期: 2015年02月01日 內容資訊: 英文 214 Pages
簡介

本報告提供全球血液析離設備市場相關調查,提供您血液析離概要及技術概要,產品開發趨勢,今後預測,以及各地區趨勢,企業簡介等彙整資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 序論
    • 捐血析離
    • 治療用血液析離大幅成長
    • 已開發國家即使主導市場,未來性來看發展中國家仍舊將取而代之
    • 生物醫藥品企業的血漿需求增加
    • 採血需求的持續擴大對血液析離設備市場而言前景看好
    • 競爭環境 其他
  • 主要的市場趨勢和促進因素
    • 癌症發病率的上升促進血液析離治療數量
    • 技術的進步與新適應症擴大了市場
    • 剖腹手術上的自動血液處理系統
    • 醫療費擴大促進需求
    • 高齡化:推動成長要素
    • 主要課題和問題
    • 患者的缺乏認知阻礙了市場成長 其他
  • 技術概要
    • 定義
    • 血液析離與全採血
    • 血液析離的工程
    • 血液組成
    • 血液析離次序
    • 血液析離的期間,頻率,效率 其他
    • 整合:主要趨勢
  • 血液組成和衍生物
  • 產品開發/認證
  • 近幾年的產業活動
  • 主要企業
    • 旭化成醫學株式會社
    • B Braun Melsungen AG
    • Cerus Corporation
    • Fresenius Kabi
    • Fenwal, Inc.
    • Haemonetics Corporation
    • HemaCare Corp.
    • 株式會社Kaneka
    • 川澄化學工業株式會社
    • Medica SpA
    • NIKKISO Europe GmbH
    • Terumo BCT, Inc.
    • Therakos, Inc.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
  • 亞太地區
    • 澳洲
    • 中國
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1237

This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousands by the following Types: Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis. Global market is analyzed by the following Applications: Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as -

Asahi Kasei Medical Co., Ltd.
B Braun Melsungen AG
Cerus Corporation
Fresenius Kabi
Haemonetics Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Prelude
  • Donor Apheresis: Dominating Equipment Sales
    • Table 1: Active Donors of Whole Blood and Apheresis per 1,000 Population by Country/Agency (2012) (includes corresponding Graph/Chart)
    • Table 2: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2012) (includes corresponding Graph/Chart)
  • Therapeutic Apheresis to Witness Strong Growth
  • Developed Markets Lead, Developing Nations to Lead the Charge in Future
  • Rising Demand for Plasma from Biopharmaceutical Companies - Opportunity to Tap
  • Sustained Growth in Blood Collections Favors Apheresis Equipment Market
    • Table 3: Total Blood Collections (2014): Percentage Share Breakdown of Collections (Units) by Segment - Whole Blood and Apheresis (includes corresponding Graph/Chart)
    • Table 4: Total Blood Collections (2014): Percentage Share Breakdown of Collections (Units) for Leukoreduced and Non-Leukoreduced Blood (includes corresponding Graph/Chart)
  • Competitive Landscape
    • Table 5: Leading Players in the Global Apheresis Systems Market (2013): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
    • Table 6: Leading Players in the Global Blood Component Collection Market (2013E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo Corp and Others (includes corresponding Graph/Chart)
  • Terumo Banks on Growing Apheresis Market
  • Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers

2. KEY MARKET TRENDS & DRIVERS

  • Rising Cancer Incidence to Drive Volume of Apheresis Procedures
    • Table 7: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
    • Table 8: World Cancer Incidence (2012): Number of New Cancer Cases Reported (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart)
    • Table 9: World Cancer Mortality (2012): Number of Cancer-Related Deaths (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart)
    • Table 10: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
  • Technological Advancements and Novel Indications Augur Well for Apheresis Market
  • Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
  • Photopheresis: A Popular Therapeutic Apheresis Procedure
  • Plasmapheresis Continues to Lead the Apheresis Market
    • Table 11: Plasma Collection Methods: Percentage Share Breakdown by Fractionation and Extraction from Whole Blood (2013 Vs. 2010) (includes corresponding Graph/Chart)
  • Plateletpheresis Emerges as the 'Treatment of Choice'
  • Increase in Number of Platelet Donors Drives Apheresis Procedures
  • Pediatrics: An Unexplored Domain in Therapeutic Apheresis
  • Automated Blood Processing Systems in Open Heart Surgeries
  • CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
  • Improving Healthcare Expenditure to Drive Demand
    • Table 12: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 13: Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
  • Aging Population: A Strong Growth Driver
    • Table 14: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 15: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 16: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Key Challenges & Issues
  • Lack of Awareness among Patients Restrains Market Growth
  • Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
  • Development of Inexpensive Apheresis Therapies
  • Scarcity of Qualified Donors
  • Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment

3. TECHNOLOGY OVERVIEW

  • Apheresis - The Definition
  • Apheresis Vs Whole Blood Collection
  • Comparison of Apheresis and Whole Blood Collection
  • The Process of Apheresis - An Overview
  • Blood Components
  • Apheresis Procedure
  • Duration, Frequency, and Efficiency of Apheresis
  • Segregation of Blood Components
  • Centrifugation
  • Centrifugal Cell Separators
  • Filtration
  • Side Effects
  • Types of Apheresis Procedures
  • Plasmapheresis
    • Plasma Exchange and Plasmapheresis: The Difference
    • Therapeutic Plasma Exchange (TPE) or Plasma Exchange
      • TPE: Abnormal Components Removed from Blood
    • Plasmapheresis: Potential Uses Discovered in the Early Years
      • Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
  • Erythrocytapheresis
  • Plateletpheresis
  • Leukapheresis
  • Photopheresis
    • Functioning of THERAKOS™ - A Typical Photopheresis System
  • Lipidpheresis
  • Cytapheresis
  • Stem Cell Collection
  • Apheresis - A Review of Segmentation
  • Donor Apheresis
    • Process of Donor Apheresis
    • Automated Blood Donation Procedures
    • Safety of the Donor
      • Blood Components Required by Different Patients
  • Automated Apheresis
  • Therapeutic Apheresis: An Introduction
    • Therapeutic Apheresis Techniques
    • Applications of Therapeutic Apheresis
      • Categories of Indications for Therapeutic Apheresis
      • Therapeutic Apheresis is Remedial for Various Diseases
      • Indications for Therapeutic Apheresis
      • Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
      • Emerging Applications of Therapeutic Apheresis
    • Cost of Select Therapeutic Apheresis Procedures: An Overview
      • 1. Photopheresis in GVHD (Graft-Versus-Host Disease)
      • 2. Lipid Apheresis (LDL Apheresis)
      • 3. Plasmapheresis and Other Procedures
    • Therapeutic Apheresis: What is the Risk Involved?
    • Replacement Fluid in Therapeutic Apheresis
      • Replacement Fluids Used in Therapeutic Apheresis
      • Various Replacement Fluids in Use
      • Select Replacement Fluids and their Limitations
    • Table 17: Fluid Balance in Fluid Replacement
    • Table 18: Volume Exchange of Plasma Constituents (includes corresponding Graph/Chart)
    • Table 19: Removal of IgM and IgG by Plasma Exchange Volume (includes corresponding Graph/Chart)
    • Table 20: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components
      • Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
    • Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

4. BLOOD COMPONENTS & DERIVATIVES

  • Red Blood Cells (RBCs)
  • White Blood Cells (WBCs)
  • Platelets
  • Sources of Blood Plasma
  • Facts About Plasma and its Donation
  • Pre-requisites for Plasma Donors
    • The Complex Process of Becoming a Donor
    • Medical Screening
    • The Process of Plasma Donation
    • Select IQPP-authorized Plasma Collection Centers (US)
  • Ionic Composition of Blood
  • Types of Blood
  • General Facts about Blood
  • General Uses of Blood
  • Blood - Global Facts

5. PRODUCT DEVELOPMENTS/APPROVALS

  • FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System
  • Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
  • USFDA Clears PMN Protocol for Terumo's Spectra Optia
  • Fenwal's Aurora Plasmapheresis System Receives 60601-1 3rd Edition Certification
  • Terumo BCT Receives 510(k) FDA Clearance for RBCX On Spectra Optia
  • Health Canada Clears BMP Protocol on Terumo's Spectra Optia
  • Terumo BCT Receives FDA Approval for Enhancement to MNC Collection Protocol for Spectra Optia System
  • Fenwal Unveils Aurora™ Plasmapheresis System
  • Terumo BCT Introduces MNC Collection Protocol for Spectra Optia System
  • Terumo BCT Unveils New Therapeutic Apheresis Capabilities and Procedures
  • Terumo BCT Obtains FDA Approval for PF24 and PF24RT24 on TrimaAccel System
  • Fenwal Secures US FDA Approval for Therapeutic Plasma Exchange Protocol on Amicus® Separator

6. RECENT INDUSTRY ACTIVITY

  • Terumo BCT Files FDA Submission to Improve Blood Supply Safety
  • Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
  • Terumo opens Production Facility in Vietnam
  • Terumo Collaborates with Kaneka
  • Terumo to Distribute Therakos Products in Latin America
  • Terumo Enters Distribution Agreement with Therakos
  • The Gores Group Acquires Therakos from Ortho-Clinical Diagnostics
  • Terumo BCT to Acquire Medservice
  • Fresenius Kabi Acquires Fenwal Holdings
  • CaridianBCT Collaborates with Terumo Transfusion to Form Terumo BCT
  • Cerus to Enter into Partnership with BSI and American Red Cross to Commercialize INTERCEPT Plasma

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Asahi Kasei Medical Co., Ltd. (Japan)
  • B Braun Melsungen AG (Germany)
  • Cerus Corporation (US)
  • Fresenius Kabi (Germany)
  • Fenwal, Inc. (US)
  • Haemonetics Corporation (US)
  • HemaCare Corp. (US)
  • Kaneka Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Medica SpA (Italy)
  • NIKKISO Europe GmbH (Germany)
  • Terumo BCT, Inc. (US)
  • Therakos, Inc. (US)

8. GLOBAL MARKET PERSPECTIVE

    • Table 21: World Recent Past, Current & Future Analysis for Apheresis Equipment Market by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Apheresis Equipment Market by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for Apheresis Equipment Market by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 24: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 26: World 14-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for Equipment for Donor Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type - Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Apheresis Equipment by Procedure Type - Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for Apheresis Equipment by Procedure Type - Percentage Breakdown of Dollar Sales for Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Apheresis Market - An Overview
    • Opportunity Indicator:
    • Table 33: US Market for Blood Collection by Type (2015E): Percentage Breakdown of Apheresis and Whole Blood Collection Procedures for Platelets and RBC (includes corresponding Graph/Chart)
    • Blood Donations
    • Table 34: Blood Transfusions per 1000 population in the US (2012-2017) (includes corresponding Graph/Chart)
      • Blood Supply and Demand in the US - A Fact Sheet
      • Criteria for Platelet Donation
      • Criteria for Double Red Cell Donation
      • Plasma Donations
    • Table 35: Number of Plasma Donations Required Annually by Disease Type in the US (2012) (includes corresponding Graph/Chart)
    • Therapeutic Apheresis Registers Strong Growth
    • Table 36: US Market for Apheresis Equipment (2015E): Percentage Share Breakdown of Revenues Generated Through Procedures by Therapeutic Area (includes corresponding Graph/Chart)
    • Competitive Scenario
    • Table 37: Leading Players in the US Automated Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Fresenius, Haemonetics, and Terumo (includes corresponding Graph/Chart)
    • Table 38: Leading Players in the US Whole Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Fresenius, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
    • Table 39: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2013): Percentage Share Breakdown of Revenues for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
    • Table 40: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2013): Percentage Share Breakdown of Number of Procedures for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
    • Table 41: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2013): Percentage Share Breakdown of Revenues for Fresenius Kabi, Terumo BCT, Therakos, and Others (includes corresponding Graph/Chart)
    • Table 42: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2013): Percentage Share Breakdown of Number of Procedures for Fresenius Kabi, Terumo BCT, and Others (includes corresponding Graph/Chart)
      • Trima Accel, the Most Widely Used Platelet Collection Equipment in the US
    • Consolidation of Blood Collectors and Healthcare Providers Puts Pricing Pressure on Suppliers
    • Implications of Healthcare Reforms
    • An Overview of Regulatory Environment and Reimbursement Scenario
      • Reimbursement Policies to Create Growth Opportunities for Therapeutic Apheresis
      • Medicaid Coverage for Therapeutic Apheresis by Various Conditions
      • Medicaid Coverage for Therapeutic Plasma Exchange
      • Medicaid covers therapeutic Cytapheresis for the following conditions:
      • Medicaid covers Extracorporeal Photopheresis (ECP) for the following conditions
    • Table 43: Payment Rates for Apheresis Procedures in 2013 & 2014 (In US$) (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 44: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: US Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: US 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Product Approval
  • B. Market Analytics
    • Table 47: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: Canadian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 49: Canadian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Therapeutic Apheresis Market - An Overview
    • Growing Demand for Cancer Treatments Drives Plateletpheresis Market
    • Key Statistics
    • Table 50: Leading Companies in the Japanese Whole Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Kawasumi and Terumo (includes corresponding Graph/Chart)
    • Table 51: Leading Companies in the Japanese Automated Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Terumo and Haemonetics (includes corresponding Graph/Chart)
    • Select Players
  • B. Market Analytics
    • Table 52: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 53: Japanese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 54: Japanese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Blood Banking in Europe
    • Table 55: Leading Players in the European Whole Blood Collection Market (2013): Percentage Share Breakdown of Volume Sales for Fresenius, MacoPharma, Terumo and Others (includes corresponding Graph/Chart)
    • Table 56: Leading Players in the European Automated Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Fresenius, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 57: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 58: European Historic Review for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 59: European 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 60: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 61: European Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 62: European 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 63: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 64: French Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 65: French 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Select Players
  • B. Market Analytics
    • Table 66: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 67: German Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 68: German 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current & Future Analysis
    • Medica Spa - A Select Player
  • B. Market Analytics
    • Table 69: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 70: Italian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 71: Italian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analysis
    • Table 72: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 73: UK Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 74: UK 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 75: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 76: Spanish Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 77: Spanish 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • Market Analysis
    • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 79: Rest of Europe Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 80: Rest of Europe 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • Market Analysis
    • Table 81: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 82: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 83: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 86: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. AUSTRALIA

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 87: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 88: Australian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 89: Australian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5b. CHINA

  • Market Analysis
    • Table 90: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 91: Chinese Historic Review for Apheresis Equipment by Segment -Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 92: Chinese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 93: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 94: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 95: Rest of Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 96: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Rest of World Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 98: Rest of World 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top